Rx Outlook

Curious to hear what you all think about the outlook of Rx for the short and long term. I’m not convinced that the actions of the current administration will lead to a recession, but general softness in the economy and inflation being higher than 2% (in the 2.25-2.75%) range seem to be more structural issues for our economy which could be good for Rx deal flow. 
Long term, I can’t see how the federal government can sustain these debt levels without it leading to austerity measures which will definitely be bad for the economy in the short term. 

 

4 Comments
 

Short term it will likely be much of the same, maybe BKs tick up but there’s so much credit both flowing in the system and on these companies balance sheets it will need to get worked out, even if rates come down.  It’s an interesting question particularly IMO when it comes to AI long term. 

Intuition says restructuring outlook would be bullish with the sheer amount of disruption coming, asymmetry across industries to those who adopt first, overcapacity, risks to capex, etc.


Flip side of this coin might suggest that the cost reduction, operational agility, labor-light models and general productivity gains achieved through AI would limit restructurings as businesses adapt and weather the storm


I don’t think it will be mass liquidations, maybe something closer to large scale consolidation across industries as reality sets in


Curious what others think

 

Amet ut molestiae corporis ut dolores qui adipisci repudiandae. Commodi ab ut cum eveniet modi possimus.

Sed ut vel molestiae a incidunt magni. Omnis cum accusantium id voluptatibus minus quisquam beatae nulla. Suscipit aut voluptatem est qui.

Cupiditate in rerum exercitationem. Veritatis at quo ut dolores voluptatem incidunt.

Career Advancement Opportunities

May 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

May 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

May 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

May 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (65) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
DrApeman's picture
DrApeman
98.9
7
GameTheory's picture
GameTheory
98.9
8
CompBanker's picture
CompBanker
98.9
9
dosk17's picture
dosk17
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”